CIPLA ISOPRENALINE isoprenaline hydrochloride 1.0 mg/5 mL injection solution ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

cipla isoprenaline isoprenaline hydrochloride 1.0 mg/5 ml injection solution ampoule

cipla australia pty ltd - isoprenaline hydrochloride, quantity: 1 mg - injection, solution - excipient ingredients: disodium edetate; sodium chloride; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - cipla isoprenaline is indicated: - for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. - for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation) (see section 4.3 contraindications). - for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available (see section 4.3 contraindications). - for brochospasm occurring during anaesthesia. - as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cariodgenic shock (see section 4.4 special warnings and precautions for use).

CIPLA ISOPRENALINE isoprenaline hydrochloride 0.2 mg/1 mL injection solution ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

cipla isoprenaline isoprenaline hydrochloride 0.2 mg/1 ml injection solution ampoule

cipla australia pty ltd - isoprenaline hydrochloride, quantity: 200 microgram - injection, solution - excipient ingredients: disodium edetate; sodium chloride; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - cipla isoprenaline is indicated: - for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. - for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation) (see section 4.3 contraindications). - for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available (see section 4.3 contraindications). - for brochospasm occurring during anaesthesia. - as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cariodgenic shock (see section 4.4 special warnings and precautions for use).

ISOPRENALINE HYDROCHLORIDE MEDSURGE isoprenaline hydrochloride 1.0 mg/5 mL injection solution ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

isoprenaline hydrochloride medsurge isoprenaline hydrochloride 1.0 mg/5 ml injection solution ampoule

medsurge pharma pty ltd - isoprenaline hydrochloride, quantity: 1 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride; disodium edetate; sodium citrate dihydrate; citric acid - isoprenaline hydrochloride is indicated: for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.,for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications),for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.),for bronchospasm occurring during anaesthesia.,as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use).

ISOPRENALINE HYDROCHLORIDE MEDSURGE isoprenaline hydrochloride 0.2 mg/1 mL injection solution ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

isoprenaline hydrochloride medsurge isoprenaline hydrochloride 0.2 mg/1 ml injection solution ampoule

medsurge pharma pty ltd - isoprenaline hydrochloride, quantity: 200 microgram - injection, solution - excipient ingredients: sodium citrate dihydrate; sodium hydroxide; hydrochloric acid; sodium chloride; disodium edetate; citric acid; water for injections - isoprenaline hydrochloride is indicated: for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.,for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications),for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.),for bronchospasm occurring during anaesthesia.,as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use).

Isoprenaline Macure 0.2 mg/ml concentrate for solution for infusion Malta - English - Medicines Authority

isoprenaline macure 0.2 mg/ml concentrate for solution for infusion

macure pharma aps hejrevej 39, dk-2400 copenhagen nv , denmark - isoprenaline hydrochloride - concentrate for solution for infusion - isoprenaline hydrochloride 0.2 mg/ml - cardiac therapy

Isoprenaline hydrochloride Macure 0.2 mg/ml concentrate for solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

isoprenaline hydrochloride macure 0.2 mg/ml concentrate for solution for infusion

macure pharma aps - isoprenaline hydrochloride - concentrate for solution for infusion - 0.2 milligram(s)/millilitre - isoprenaline

Isoprenaline Phagecon 1 mg/5 ml, concentrate for solution for infusion.  St Malta - English - Medicines Authority

isoprenaline phagecon 1 mg/5 ml, concentrate for solution for infusion. st

phagecon - serviços e consultoria farmacêutica, lda. avenida josé malhoa, nº2 edifício malhoa plaza, 3º piso, escritório 3.7 1070-325 lisboa , portugal - isoprenaline hydrochloride - concentrate for solution for infusion - isoprenaline hydrochloride 1 mg/5ml - cardiac therapy

ISOPRENALINE MACURE isoprenaline hydrochloride 1 mg/5 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

isoprenaline macure isoprenaline hydrochloride 1 mg/5 ml solution for injection ampoule

juno pharmaceuticals pty ltd - isoprenaline hydrochloride, quantity: 1 mg - injection, solution - excipient ingredients: sodium citrate dihydrate; water for injections; sodium hydroxide; hydrochloric acid; sodium chloride; citric acid monohydrate; disodium edetate - for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications.) for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.) for bronchospasm occurring during anaesthesia. as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use)

Isoprenaline HCl Macure 0,2 mg/ml inf. sol. (conc.) i.v. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

isoprenaline hcl macure 0,2 mg/ml inf. sol. (conc.) i.v. amp.

macure pharma aps - isoprenaline hydrochloride 0,2 mg/ml - eq. isoprenaline 0,17 mg/ml - concentrate for solution for infusion - 0,2 mg/ml - isoprenaline hydrochloride 0.2 mg/ml - isoprenaline